INTERVIEW WITH SAHPRA BOARD CHAIR, PROF HELEN REES (SAHPRA 2020)

04 Feb INTERVIEW WITH SAHPRA BOARD CHAIR, PROF HELEN REES (SAHPRA 2020)

Posted at 10:03h in News & Updates by Ntokozo Msiza

Facebook Feed

5 days ago

Media release:

SAHPRA has received documentation for the SputnikV vaccine developed by the Gamaleya Institute in Russia on 24 February 2021.

Read more: https://bit.ly/3u7Hol1
#vaccinecovid19 #SAHPRA #sputniknews ... See more

SAHPRA has received documentation for the SputnikV vaccine developed by the Gamaleya Institute in Russia on 24 February 2021.

View on facebook

1 week ago

SAHPRA and Rollout to President and Deputy President

Media release:

SAHPRA has approved the protocol amendment of the J&J implementation study targeted at Health Care Workers (HCW) for the inclusion of the President and the Deputy President. Whilst ... See more

SAHPRA has approved the protocol amendment of the J&J implementation study targeted at Health Care Workers (HCW)...

View on facebook

1 week ago

SAHPRA and the SputnikV vaccine

Media release:

SAHPRA has NOT received documentation for the SputnikV vaccine developed by the Gamaleya Institute in Russia as has been reported.

Read more: https://bit.ly/3u7Hol1

#vaccinecovid19 #SAHPRA #sputniknews ... See more

SAHPRA has NOT received documentation for the SputnikV vaccine developed by the Gamaleya Institute in Russia as has been reported.

View on facebook

2 weeks ago

Carte Blanche Ivermectin

Carte Blanche on Ivermectin: CEO and Board Chair of SAHPRA discuss the Ivermectin issue

CEO and Board Chair of SAHPRA discuss the Ivermectin issue

View on facebook

4 weeks ago

SAHPRA clarifies its stance on Ivermectin

There is an erroneous notion that SAHPRA “buckled under pressure” as a consequence of the court action brought by, amongst others the Afriforum regarding access to Ivermectin. SAHPRA wishes to ... See more

There is an erroneous notion that SAHPRA “buckled under pressure” as a consequence of the court action brought by, amongst others Afriforum.

View on facebook

1 month ago

SAHPRA AUTHORISES COVISHIELD - AN ADENOVIRUS-VECTORED VACCINE FOR THE PREVENTION OF COVID-19 - SAHPRA

In an effort to enable and support the country’s response in fighting the #COVID19 pandemic, SAHPRA has on 22 January 2021 granted a Section 21 authorisation to the National Department of Health ... See more

In an effort to enable and support the country’s response in fighting the COVID-19 pandemic, SAHPRA has on 22 January 2021 granted a Section 21 authorisation to the Department of Health for ... See more

View on facebook

1 month ago

Media Briefing on Ivermectin

The South African Health Products Regulatory Authority (SAHPRA) holds a press conference to brief the media on the latest update regarding Ivermectin.

View on facebook

1 month ago

HealthTalk SABC 21Jan2021

Follow the discussion on Ivermectin on SABC 2

View on facebook

1 month ago

Good evening

Please note that the press conference scheduled for Monday, 25 January 2021 has been canceled.

The National Department of Health (South Africa) will hold a similar press conference on ... See more

View on facebook

1 month ago

National Department of Health (South Africa)

Scientific Discussion on the new variant, 501Y.V2

View on facebook

« ‹ 1 of 2 › »

Twitter Feed

SAHPRAFollow

Retweet on Twitter SAHPRA Retweeted

NICD@nicd_sa·

17h

#COVID19 UPDATE: A total of 23 753 tests were conducted in the last 24 hrs, with 856 new cases, which represents a 4% positivity rate. A further 194 #COVID19 related deaths have been reported, bringing total fatalities to 50 271 to date. Read more here http://ow.ly/gGmM50DOc1P

Reply on Twitter 1366825421220831240 Retweet on Twitter 136682542122083124035 Like on Twitter 136682542122083124056 Twitter 1366825421220831240

04 Feb INTERVIEW WITH SAHPRA BOARD CHAIR, PROF HELEN REES (SAHPRA 2020)

SAHPRA clarifies its stance on Ivermectin

SAHPRA AUTHORISES COVISHIELD – AN ADENOVIRUS-VECTORED VACCINE FOR THE PREVENTION OF COVID-19

SAHPRA OTC ONLINE DIRECTORY

Extension of Post Importation Testing Exemptions

Frequently Asked Questions: New Variant of SARS-CoV-2 in South Africa

INFORMATION AND GUIDANCE ON IMMUNIZATION WITH THE NEW COVID-19 VACCINES

CONTACT US

Quick Menu

I want to..

Newsletter Subscription

Follow us